GeneGoCell Insights

Stay informed, stay productive with all the latest from GeneGoCell.

G-Amp-HT℠ High-Throughput NGS Genotyping

By Dr. Aaron Zhang-Chen, CQA, PhD on September 14, 2026

Explore G-Amp-HT℠, GeneGoCell’s high-throughput NGS genotyping workflow for 1% allele-frequency resolution, rapid clone screening, and multi-sample studies.

G-Amp-HT℠High-Throughput NGS Genotyping Genome Editing Verification Clone Genotyping Cell And Gene Therapy NGS Testing Cell Line Engineering

G-GUIDE℠ Off-Target Analysis: High-Sensitivity CRISPR Off-Target Identification with Optimized GUIDE-Seq

By Dr. Aaron Zhang-Chen, CQA, PhD, CTO at GeneGoCell on September 7, 2026

Learn how GeneGoCell’s licensed G-GUIDE℠ workflow enables genome-wide CRISPR off-target identification with 0.005% LOD and under two-week turnaround time.

G-GUIDE℠Off-Target analysis CRISPR off-target identification Genome Editing Verification Genome Editing Safety Cell And Gene Therapy

What Must Be Measured, and What Can Be Shared: NGS, prior knowledge, and genome-editing safety in three 2026 FDA publications

By Dr. Aaron Zhang-Chen, CQA, PhD on August 31, 2026

What do three 2026 FDA guidance/recommendation mean for genome editing? Learn what NGS safety data should be measured, what prior knowledge can be reused, and when.

Genome Editing Safety Genome Editing Verification Off-target Analysis Chromosomal Translocation Analysis Cell and Gene Therapy FDA Gene Therapy Guidance

In Vivo CAR Beyond Treating Cancer: From Immune Reset to a New Measurement Challenge

By Dr. Elizabeth Yan Zhang, CMQ/OE, MBA, PhD, Founder and CEO, GeneGoCell on August 24, 2026

Explore how CAR therapy is moving beyond cancer toward autoimmune immune reset and in vivo engineering, and why analytical characterization must evolve with it.

in vivo CAR CAR cell therapy Genome Editing Verification Cell and Gene Therapy CAR cell therapy beyond cancer

Detection and Quantification of Integration using Genome Editing Verification (GEV℠) Integration (G-Int℠) Workflow

By Dr. Aaron Zhang-Chen, CQA, PhD on August 17, 2026

Explore GeneGoCell’s G-Int℠ NGS workflows for integration site identification, integration efficiency analysis, and transgene integrity analysis after genome editing.

Genome Editing Verification G-LMP℠G-Int℠GEV℠Genome Editing Integration Analysis Integration Site Analysis Transgene Integrity Cell and Gene Therapy

Identifying and Quantifying Structural Variants using Genome Editing Verification (GEV℠) Translocation (G-Trans℠) Workflow

By Dr. Aaron Zhang-Chen, CQA, PhD on August 10, 2026

Learn how G-Trans uses UMI-enabled, ligation-mediated NGS to identify and quantify genome-wide chromosomal translocations after genome editing.

Genome Editing Verification G-LMP℠G-Trans℠GEV℠Genome Editing Translocation Analysis Chromosomal Translocation Analysis

UC San Diego OPALS Students Explore Biotechnology and Genome Editing at GeneGoCell

By Dr. Elizabeth Yan Zhang, CMQ/OE, MBA, PhD, Founder and CEO, GeneGoCell on August 3, 2026

UC San Diego OPALS students visited GeneGoCell to explore biotechnology careers, NGS, genome-editing verification, laboratory quality systems, and scientific entrepreneurship.

STEM education San Diego CGT testing Outreach to UC San Diego STEM Genomics Genome Editing Verification Biotech Entrepreneurship

Evidence Before Hope: Safety, Ethics, Independent Verification, and Public Education in Genome Editing

By Dr. Elizabeth Yan Zhang, CMQ/OE, MBA, PhD, Founder and CEO, GeneGoCell on July 27, 2026

Genome editing requires rigorous safety data, ethical oversight, independent verification, transparent reporting, and accessible public education before clinical translation.

Genome Editing Safety Genome Editing Verification Genome Editing Ethics Independent Verification

High-Resolution, Customizable, and Cost-Effective: Genome Editing Verification (GEV℠) G-Amp℠ Workflow Delivers It All

By Dr. Aaron Zhang-Chen, CQA, PhD on July 21, 2026

Discover how GeneGoCell's Genome Editing Verification (GEV℠) G-Amp℠ platform improves multiplex targeted amplicon sequencing with dual-amplicon, UMI technology for accurate, sensitive, and cost-effective NGS analysis of gene editing outcomes.

Genome Editing Verification On-target Verification Off-target Analysis G-Amp℠GEV℠